OWC Pharmaceutical Research Corp (OWCP)

[nonewname1]

A tube of topical psoriasis medications might cost between $500 and $600. And biologics, a relatively new class of treatment for psoriasis and psoriatic arthritis, can run $15,000 to $20,000 or more a year.

http://www.everydayhealth.com/psoriasis/treatment/ways-to-manage-the-cost-of-psoriasis-treatments/


I'm guessing the $500 tube doesn't last all year either, there is no cure. I'm guessing our treatment will be cheaper which is why there is interest in it? Still, even if we are cheaper by half and thus cornered 5% of the market (just in the U.S.) that's 11 million just for one tube, if patients need 5 to 6 tubes a year that could be 50 mill in revenue.

What I'm saying is don't be fooled by the low number of people that have psoriasis, it could mean big money for this company, considering we are trading at a 3 mil market cap.

Did anyone ever find any other public companies taking a truly clinical approach to mj treatments? What is their market cap?